Fibromyalgia syndrome (FM) is a condition of chronic and diffuse muscular pain affecting particularly middle aged women. The aetiology of FM is not completely understood and it is currently considered a disorder of pain regulation. The most efficacious compounds include the tricyclic drugs and mixed reuptake inhibitors. Recent works suggest that the anticonvulsant medications pregabalin and gabapentin are also effective. Moreover, two serotonin and norepinephrine-reuptake inhibitors-duloxetine and milnacipran show encouraging results in treating FM symptoms. The results of clinical trials of anti-inflammatory medications have been generally disappointing, but three RCTs have found that tramadol (with or without acetaminophen) is effective in FM.

La terapia farmacologica della fibromialgia = Pharmacological treatment of fibromyalgia / M. Cazzola, P. Sarzi-Puttini, D. Buskila, F. Atzeni. - In: REUMATISMO. - ISSN 0048-7449. - 59:4(2007 Oct), pp. 280-291. [10.4081/reumatismo.2007.280]

La terapia farmacologica della fibromialgia = Pharmacological treatment of fibromyalgia

P. Sarzi-Puttini;
2007

Abstract

Fibromyalgia syndrome (FM) is a condition of chronic and diffuse muscular pain affecting particularly middle aged women. The aetiology of FM is not completely understood and it is currently considered a disorder of pain regulation. The most efficacious compounds include the tricyclic drugs and mixed reuptake inhibitors. Recent works suggest that the anticonvulsant medications pregabalin and gabapentin are also effective. Moreover, two serotonin and norepinephrine-reuptake inhibitors-duloxetine and milnacipran show encouraging results in treating FM symptoms. The results of clinical trials of anti-inflammatory medications have been generally disappointing, but three RCTs have found that tramadol (with or without acetaminophen) is effective in FM.
Adjuvants, Immunologic; Age Factors; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents; Anticonvulsants; Antidepressive Agents, Tricyclic; Dopamine Agonists; Drug Therapy, Combination; Female; Fibromyalgia; GABA Agonists; Humans; Randomized Controlled Trials as Topic; Risk Factors; Serotonin Uptake Inhibitors; Sex Factors; Treatment Outcome
Settore MED/16 - Reumatologia
ott-2007
Article (author)
File in questo prodotto:
File Dimensione Formato  
document (9).pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 87.47 kB
Formato Adobe PDF
87.47 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/667044
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 9
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact